Clinical trial · people
GHRP-2: 30-day infusion raised GH and IGF-I in older adults
Checked against the paper Clinical trialPublished by PepVault
The takeaway
In healthy older adults, a month of steady GHRP-2 kept GH above saline levels, though less than on day 1, and held IGF-I at a stable higher level. This shows hormone changes, not health effects.
- Kind
- Clinical trial
- Studied in
- People
- Published
- 2004
- Journal
- J Clin Endocrinol Metab
What they tested
The team tested whether GHRP-2, alone or with GHRH (GH-releasing hormone), raises growth hormone (GH) output in healthy older adults, and whether a 30-day steady infusion keeps GH, IGF-I and two IGF-binding proteins raised.
How the study was done
A three-part human study in healthy older men and women, with young volunteers added for one part. It used one-time injections into a vein (17 older and 16 young volunteers), 24-hour infusions under the skin of GHRP-2, GHRH or both, and a 30-day continuous infusion of GHRP-2 under the skin in 17 people, compared with saline (salt water) and with baseline.

What they found
Over 30 days of GHRP-2 infusion, GH secretion rose more than 3-fold on day 1 and more than 1.8-fold on days 14 and 30 compared with saline (each P < 0.001). IGF-I rose to a steady higher level on days 1, 14 and 30, and the binding proteins IGFBP-3 and IGFBP-5 went up on day 14, day 30 or both. In the 24-hour infusions, GHRP-2 plus GHRH raised GH more than either one alone. With one-time injections, the combined boost from the two peptides was 3-fold greater in young than older volunteers and 2.3-fold greater in older women than older men. Safety screening tests stayed normal.
What it doesn’t show
Everyone was a healthy volunteer, and the longest part of the study lasted 30 days. It tracked hormone and binding-protein levels plus safety screening tests, not health outcomes.
The paper
Bowers et al. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women. J Clin Endocrinol Metab. 2004.
The compound
More studies on GHRP-2
- GHRP-2: 35.9% more food eaten at a buffet meal in healthy menClinical trial · people · 2005
- GHRP-2: stronger GH release than GHRH in 6 healthy young adultsClinical trial · people · 1997
- GHRP-2: chronic dosing made GH response to GHRH combo synergisticClinical trial · people · 1996
- Every study on GHRP-2
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.